{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T12:37:08Z","timestamp":1778071028189,"version":"3.51.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T00:00:00Z","timestamp":1649030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T00:00:00Z","timestamp":1649030400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100010909","name":"young scientists fund","doi-asserted-by":"publisher","award":["81402848"],"award-info":[{"award-number":["81402848"]}],"id":[{"id":"10.13039\/501100010909","id-type":"DOI","asserted-by":"publisher"}]},{"name":"biosafety project foundation","award":["19SWAQ13"],"award-info":[{"award-number":["19SWAQ13"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Cognitive impairment is one of the primary sequelae affecting the quality of life of patients with Japanese encephalitis (JE). The clinical treatment is mainly focused on life\u00a0support, lacking of targeted treatment strategy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A cerebrospinal fluid (CSF) proteomic profiling study was performed including 26 patients with JE in Gansu province of China from June 2017 to October 2018 and 33 other concurrent hospitalized patients who were excluded central nervous system (CNS) organic or CNS infection diseases. The clinical and proteomics data of patients with JE were undergoing combined analysis for the first time.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Two subtypes of JE associated with significantly different prognoses were identified. Compared to JE1, the JE2 subtype is associated with lower overall survival rate and a higher risk of cognitive impairment. The percentages of neutrophils (N%), lymphocyte (L%), and monocytes (M%) decreased in JE2 significantly.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The differences in proteomic landscape between JE subgroups have specificity for the prognosis of cognitive impairment. The data also provided some potential target proteins for treatment of cognitive impairments caused by JE.<\/jats:p><jats:p><jats:italic>Trial registration<\/jats:italic>ChiCTR, ChiCTR2000030499. Registered 1st June 2017,<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.medresman.org.cn\/pub\/cn\/proj\/projectshow.aspx?proj=6333\">http:\/\/www.medresman.org.cn\/pub\/cn\/proj\/projectshow.aspx?proj=6333<\/jats:ext-link><\/jats:p><\/jats:sec>","DOI":"10.1186\/s12974-022-02439-5","type":"journal-article","created":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T18:03:38Z","timestamp":1649095418000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Proteomic landscape subtype and clinical prognosis of patients with the cognitive impairment by Japanese encephalitis infection"],"prefix":"10.1186","volume":"19","clinical-trial-number":[{"clinical-trial-number":"chictr2000030499","registry":"10.18810\/chictr"}],"author":[{"given":"Rong","family":"Yin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linpeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Hao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiqi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanjun","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meiling","family":"Dan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingjie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaxuan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiping","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanyuan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0275-8312","authenticated-orcid":false,"given":"Pengcheng","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,4,4]]},"reference":[{"key":"2439_CR1","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nrneurol.2018.30","volume":"14","author":"L Turtle","year":"2018","unstructured":"Turtle L, Solomon T. Japanese encephalitis\u2014the prospects for new treatments. Nat Rev Neurol. 2018;14:298\u2013313.","journal-title":"Nat Rev Neurol"},{"key":"2439_CR2","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1016\/S0140-6736(18)31191-7","volume":"391","author":"J Im","year":"2018","unstructured":"Im J, Balasubramanian R, Yastini NW, Suwarba IGN, Andayani AR, Bura V, Jeon HJ, Clemens JD, Marks F. Protecting children against Japanese encephalitis in Bali, Indonesia. Lancet. 2018;391:2500\u20131.","journal-title":"Lancet"},{"issue":"766\u2013774","key":"2439_CR3","first-page":"774A","volume":"89","author":"GL Campbell","year":"2011","unstructured":"Campbell GL, Hills SL, Fischer M, Jacobson JA, Hoke CH, Hombach JM, Marfin AA, Solomon T, Tsai TF, Tsu VD, Ginsburg AS. Estimated global incidence of Japanese encephalitis: a systematic review. Bull World Health Organ. 2011;89(766\u2013774):774A-774E.","journal-title":"Bull World Health Organ"},{"key":"2439_CR4","doi-asserted-by":"publisher","first-page":"579","DOI":"10.15585\/mmwr.mm6622a3","volume":"66","author":"JD Heffelfinger","year":"2017","unstructured":"Heffelfinger JD, Li X, Batmunkh N, Grabovac V, Diorditsa S, Liyanage JB, Pattamadilok S, Bahl S, Vannice KS, Hyde TB, et al. Japanese encephalitis surveillance and immunization\u2014Asia and Western Pacific Regions, 2016. MMWR Morb Mortal Wkly Rep. 2017;66:579\u201383.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2439_CR5","doi-asserted-by":"publisher","first-page":"e2556","DOI":"10.1038\/cddis.2016.394","volume":"8","author":"S Mukherjee","year":"2017","unstructured":"Mukherjee S, Singh N, Sengupta N, Fatima M, Seth P, Mahadevan A, Shankar SK, Bhattacharyya A, Basu A. Japanese encephalitis virus induces human neural stem\/progenitor cell death by elevating GRP78, PHB and hnRNPC through ER stress. Cell Death Dis. 2017;8:e2556.","journal-title":"Cell Death Dis"},{"key":"2439_CR6","doi-asserted-by":"publisher","first-page":"ra98","DOI":"10.1126\/scisignal.aaf5132","volume":"9","author":"J Ye","year":"2016","unstructured":"Ye J, Zhang H, He W, Zhu B, Zhou D, Chen Z, Ashraf U, Wei Y, Liu Z, Fu ZF, et al. Quantitative phosphoproteomic analysis identifies the critical role of JNK1 in neuroinflammation induced by Japanese encephalitis virus. Sci Signal. 2016;9:ra98.","journal-title":"Sci Signal."},{"key":"2439_CR7","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s12974-021-02180-5","volume":"18","author":"AM Patil","year":"2021","unstructured":"Patil AM, Choi JY, Park SO, Uyangaa E, Kim B, Kim K, Eo SK. Type I IFN signaling limits hemorrhage-like disease after infection with Japanese encephalitis virus through modulating a prerequisite infection of CD11b(+)Ly-6C(+) monocytes. J Neuroinflammation. 2021;18:136.","journal-title":"J Neuroinflammation"},{"key":"2439_CR8","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.neuint.2009.07.006","volume":"55","author":"MK Mishra","year":"2009","unstructured":"Mishra MK, Dutta K, Saheb SK, Basu A. Understanding the molecular mechanism of blood-brain barrier damage in an experimental model of Japanese encephalitis: correlation with minocycline administration as a therapeutic agent. Neurochem Int. 2009;55:717\u201323.","journal-title":"Neurochem Int"},{"key":"2439_CR9","doi-asserted-by":"publisher","first-page":"2856","DOI":"10.1038\/nprot.2006.468","volume":"1","author":"A Shevchenko","year":"2006","unstructured":"Shevchenko A, Tomas H, Havlis J, Olsen JV, Mann M. In-gel digestion for mass spectrometric characterization of proteins and proteomes. Nat Protoc. 2006;1:2856\u201360.","journal-title":"Nat Protoc"},{"key":"2439_CR10","doi-asserted-by":"publisher","first-page":"5437","DOI":"10.1016\/j.jprot.2012.06.020","volume":"75","author":"L Arike","year":"2012","unstructured":"Arike L, Valgepea K, Peil L, Nahku R, Adamberg K, Vilu R. Comparison and applications of label-free absolute proteome quantification methods on Escherichia coli. J Proteomics. 2012;75:5437\u201348.","journal-title":"J Proteomics"},{"key":"2439_CR11","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1038\/s41467-018-03121-2","volume":"9","author":"S Ge","year":"2018","unstructured":"Ge S, Xia X, Ding C, Zhen B, Zhou Q, Feng J, Yuan J, Chen R, Li Y, Ge Z, et al. A proteomic landscape of diffuse-type gastric cancer. Nat Commun. 2018;9:1012.","journal-title":"Nat Commun"},{"key":"2439_CR12","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/nbt0308-303","volume":"26","author":"M Ringner","year":"2008","unstructured":"Ringner M. What is principal component analysis? Nat Biotechnol. 2008;26:303\u20134.","journal-title":"Nat Biotechnol"},{"key":"2439_CR13","doi-asserted-by":"publisher","first-page":"R118","DOI":"10.1186\/gb-2008-9-7-r118","volume":"9","author":"VT Chu","year":"2008","unstructured":"Chu VT, Gottardo R, Raftery AE, Bumgarner RE, Yeung KY. MeV+R: using MeV as a graphical user interface for Bioconductor applications in microarray analysis. Genome Biol. 2008;9:R118.","journal-title":"Genome Biol"},{"key":"2439_CR14","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.cmpb.2019.05.023","volume":"177","author":"M Ogluszka","year":"2019","unstructured":"Ogluszka M, Orzechowska M, Jedroszka D, Witas P, Bednarek AK. Evaluate Cutpoints: adaptable continuous data distribution system for determining survival in Kaplan-Meier estimator. Comput Methods Programs Biomed. 2019;177:133\u20139.","journal-title":"Comput Methods Programs Biomed"},{"key":"2439_CR15","doi-asserted-by":"publisher","first-page":"D353","DOI":"10.1093\/nar\/gkw1092","volume":"45","author":"M Kanehisa","year":"2017","unstructured":"Kanehisa M, Furumichi M, Tanabe M, Sato Y, Morishima K. KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 2017;45:D353\u201361.","journal-title":"Nucleic Acids Res"},{"key":"2439_CR16","doi-asserted-by":"publisher","first-page":"D447","DOI":"10.1093\/nar\/gku1003","volume":"43","author":"D Szklarczyk","year":"2015","unstructured":"Szklarczyk D, Franceschini A, Wyder S, Forslund K, Heller D, Huerta-Cepas J, Simonovic M, Roth A, Santos A, Tsafou KP, et al. STRING v10: protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 2015;43:D447-452.","journal-title":"Nucleic Acids Res"},{"key":"2439_CR17","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jneumeth.2015.05.011","volume":"251","author":"MA Collins","year":"2015","unstructured":"Collins MA, An J, Peller D, Bowser R. Total protein is an effective loading control for cerebrospinal fluid western blots. J Neurosci Methods. 2015;251:72\u201382.","journal-title":"J Neurosci Methods"},{"key":"2439_CR18","first-page":"423","volume":"69","author":"A Mathur","year":"1988","unstructured":"Mathur A, Bharadwaj M, Kulshreshtha R, Rawat S, Jain A, Chaturvedi UC. Immunopathological study of spleen during Japanese encephalitis virus infection in mice. Br J Exp Pathol. 1988;69:423\u201332.","journal-title":"Br J Exp Pathol"},{"key":"2439_CR19","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1007\/s10072-020-04867-8","volume":"42","author":"Q Su","year":"2021","unstructured":"Su Q, Xie ZX, He F, Liu ZC, Song XJ, Zhao FC, Li D, Che FY. Adults with severe Japanese encephalitis: a retrospective analysis of 9 cases in Linyi, China. Neurol Sci. 2021;42:2811\u20137.","journal-title":"Neurol Sci"},{"key":"2439_CR20","first-page":"634","volume":"125","author":"T Kuntzer","year":"1995","unstructured":"Kuntzer T, de Marval F, Ochsner F, de Torrente A, Kuhn M, Fitting JW. Meningoencephalo-myeloradiculitis due to Flavivirus: bi-brachial paralysis and respiratory insufficiency. Schweiz Med Wochenschr. 1995;125:634\u20138.","journal-title":"Schweiz Med Wochenschr"},{"key":"2439_CR21","doi-asserted-by":"publisher","first-page":"e17453","DOI":"10.1097\/MD.0000000000017453","volume":"98","author":"Q Feng","year":"2019","unstructured":"Feng Q, Chen Q, Bi X, Yu S, Wang J, Sun X, Ren C, Liu H, Guan L. Severe Japanese encephalitis with multiple intracranial hemorrhages: a case report. Medicine (Baltimore). 2019;98:e17453.","journal-title":"Medicine (Baltimore)"},{"key":"2439_CR22","first-page":"171","volume":"267","author":"T Solomon","year":"2002","unstructured":"Solomon T, Vaughn DW. Pathogenesis and clinical features of Japanese encephalitis and West Nile virus infections. Curr Top Microbiol Immunol. 2002;267:171\u201394.","journal-title":"Curr Top Microbiol Immunol"},{"key":"2439_CR23","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.jmii.2019.08.010","volume":"52","author":"SH Lo","year":"2019","unstructured":"Lo SH, Tang HJ, Lee SS, Lee JC, Liu JW, Ko WC, Chang K, Lee CY, Chang YT, Lu PL. Determining the clinical characteristics and prognostic factors for the outcomes of Japanese encephalitis in adults: a multicenter study from southern Taiwan. J Microbiol Immunol Infect. 2019;52:893\u2013901.","journal-title":"J Microbiol Immunol Infect"},{"key":"2439_CR24","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.3390\/ijms17091386","volume":"17","author":"SH Huang","year":"2016","unstructured":"Huang SH, Lien JC, Chen CJ, Liu YC, Wang CY, Ping CF, Lin YF, Huang AC, Lin CW. Antiviral activity of a novel compound CW-33 against Japanese encephalitis virus through inhibiting intracellular calcium overload. Int J Mol Sci. 2016;17:1386.","journal-title":"Int J Mol Sci"},{"key":"2439_CR25","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3389\/fmicb.2017.00213","volume":"8","author":"JN Conde","year":"2017","unstructured":"Conde JN, Silva EM, Barbosa AS, Mohana-Borges R. The complement system in flavivirus infections. Front Microbiol. 2017;8:213.","journal-title":"Front Microbiol"},{"key":"2439_CR26","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/s41586-019-0987-8","volume":"567","author":"Y Jiang","year":"2019","unstructured":"Jiang Y, Sun A, Zhao Y, Ying W, Sun H, Yang X, Xing B, Sun W, Ren L, Hu B, et al. Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma. Nature. 2019;567:257\u201361.","journal-title":"Nature"},{"key":"2439_CR27","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/0304-3940(95)11618-7","volume":"192","author":"JA Vega","year":"1995","unstructured":"Vega JA, Diaz-Trelles R, Haro JJ, del Valle ME, Naves FJ, Fernandez-Sanchez MT. Beta-amyloid precursor protein in human digital skin. Neurosci Lett. 1995;192:132\u20136.","journal-title":"Neurosci Lett"},{"key":"2439_CR28","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s11248-019-00166-x","volume":"28","author":"S Jang","year":"2019","unstructured":"Jang S, Jang WY, Choi M, Lee J, Kwon W, Yi J, Park SJ, Yoon D, Lee S, Kim MO, Ryoo ZY. Serum amyloid A1 is involved in amyloid plaque aggregation and memory decline in amyloid beta abundant condition. Transgenic Res. 2019;28:499\u2013508.","journal-title":"Transgenic Res"},{"key":"2439_CR29","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.imbio.2011.07.023","volume":"217","author":"M Aiyaz","year":"2012","unstructured":"Aiyaz M, Lupton MK, Proitsi P, Powell JF, Lovestone S. Complement activation as a biomarker for Alzheimer\u2019s disease. Immunobiology. 2012;217:204\u201315.","journal-title":"Immunobiology"},{"key":"2439_CR30","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/BF00192116","volume":"426","author":"R Veerhuis","year":"1995","unstructured":"Veerhuis R, van der Valk P, Janssen I, Zhan SS, Van Nostrand WE, Eikelenboom P. Complement activation in amyloid plaques in Alzheimer\u2019s disease brains does not proceed further than C3. Virchows Arch. 1995;426:603\u201310.","journal-title":"Virchows Arch"},{"key":"2439_CR31","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.4049\/jimmunol.138.5.1530","volume":"138","author":"SH Kim","year":"1987","unstructured":"Kim SH, Carney DF, Hammer CH, Shin ML. Nucleated cell killing by complement: effects of C5b\u20139 channel size and extracellular Ca2+ on the lytic process. J Immunol. 1987;138:1530\u20136.","journal-title":"J Immunol"},{"key":"2439_CR32","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1038\/s41591-018-0336-8","volume":"25","author":"C Yin","year":"2019","unstructured":"Yin C, Ackermann S, Ma Z, Mohanta SK, Zhang C, Li Y, Nietzsche S, Westermann M, Peng L, Hu D, et al. ApoE attenuates unresolvable inflammation by complex formation with activated C1q. Nat Med. 2019;25:496\u2013506.","journal-title":"Nat Med"},{"key":"2439_CR33","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1002\/ijc.30455","volume":"140","author":"K Ohyama","year":"2017","unstructured":"Ohyama K, Yoshimi H, Aibara N, Nakamura Y, Miyata Y, Sakai H, Fujita F, Imaizumi Y, Chauhan AK, Kishikawa N, Kuroda N. Immune complexome analysis reveals the specific and frequent presence of immune complex antigens in lung cancer patients: a pilot study. Int J Cancer. 2017;140:370\u201380.","journal-title":"Int J Cancer"},{"key":"2439_CR34","doi-asserted-by":"publisher","first-page":"4187","DOI":"10.4049\/jimmunol.179.6.4187","volume":"179","author":"S Garantziotis","year":"2007","unstructured":"Garantziotis S, Hollingsworth JW, Ghanayem RB, Timberlake S, Zhuo L, Kimata K, Schwartz DA. Inter-alpha-trypsin inhibitor attenuates complement activation and complement-induced lung injury. J Immunol. 2007;179:4187\u201392.","journal-title":"J Immunol"},{"key":"2439_CR35","doi-asserted-by":"publisher","first-page":"D1211","DOI":"10.1093\/nar\/gky869","volume":"47","author":"J Ma","year":"2019","unstructured":"Ma J, Chen T, Wu S, Yang C, Bai M, Shu K, Li K, Zhang G, Jin Z, He F, et al. iProX: an integrated proteome resource. Nucleic Acids Res. 2019;47:D1211\u20137.","journal-title":"Nucleic Acids Res"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-022-02439-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-022-02439-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-022-02439-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T16:39:17Z","timestamp":1700411957000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-022-02439-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,4]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2439"],"URL":"https:\/\/doi.org\/10.1186\/s12974-022-02439-5","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,4]]},"assertion":[{"value":"1 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of the Lanzhou General Hospital prior to initiation (2017XYLL050).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"77"}}